Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese

NCT01739049 on ClinicalTrials.gov · last registry update 2017-05-04

Finished October 2013, after enrolling 42 people. Primary outcome, as filed: Reduction in binge eating scale score.

Status: COMPLETED
Phase: P4
Drug: liraglutide
Saxenda, Victoza, Xultophy
Sponsor: Universiti Kebangsaan Malaysia Medical Centre
Sponsor type: Other
Enrollment: 42
Started: 2012-11
Primary completion: 2013-10 actual

Observed history

No changes recorded since monitoring began on 2026-08-21. This record has held steady. If a reporting date moves, a status changes or enrollment is resized, it will appear here with the previous value alongside the new one.

Primary outcome

Reduction in binge eating scale score

Conditions studied

Binge Eating Behaviour

Every field above is taken directly from the registry record. See all detected changes across the class, or the liraglutide page for this molecule’s full trial and approval history.